Article
Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
The Journal of antimicrobial chemotherapy - 11 Feb 2021
Kao Shu-Wei, Liu Zhuo-Hao, Wu Ting-Shu, Ku Stephane Wen-Wei, Tsai Chia-Lung, Shie Shian-Sen, Huang Po-Yen, Wu Yen-Mu, Hsiao Yu-Hsiang, Chen Nan-Yu
Abstract excerpt
BACKGROUND: Effective ART is crucial for combating the HIV pandemic. Clinically, plasma viral load monitoring to achieve virological suppression is the guide for an optimal ART. The presence of low-level viraemia (LLV) below the definition level of virological failure is a risk factor for ART failure. However, there is no treatment consensus over LLV yet, mainly due to the limitation of standard HIV-RNA...
Topics
- Anti-HIV Agents
- Drug Resistance, Viral
- HIV Infections
- HIV-1
- Humans
- Mutation
- Prevalence
- Taiwan
- Tertiary Care Centers
- Viral Load